• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Levoketoconazole.左酮康唑
Hosp Pharm. 2022 Oct;57(5):605-614. doi: 10.1177/00185787221115368. Epub 2022 Aug 2.
2
Formulary Drug Review: Belumosudil.处方药物审评:贝利司他
Hosp Pharm. 2022 Aug;57(4):435-441. doi: 10.1177/00185787211061381. Epub 2021 Dec 7.
3
Formulary Drug Review: Edaravone.处方药物审查:依达拉奉
Hosp Pharm. 2017 Dec;52(11):732-736. doi: 10.1177/0018578717734877. Epub 2017 Oct 9.
4
Formulary Drug Review: Ocrelizumab.处方药物评审:奥瑞珠单抗
Hosp Pharm. 2017 Oct;52(9):599-606. doi: 10.1177/0018578717731733. Epub 2017 Sep 17.
5
Formulary Drug Reviews: Glecaprevir/Pibrentasvir.处方药物评估:格卡瑞韦/哌仑他韦
Hosp Pharm. 2018 Apr;53(2):75-84. doi: 10.1177/0018578717746417. Epub 2017 Dec 11.
6
Formulary Drug Review: Odevixibat.处方药物审查:odevixibat。
Hosp Pharm. 2023 Apr;58(2):125-133. doi: 10.1177/00185787211069036. Epub 2022 Feb 8.
7
Formulary Drug Review: Rezafungin.处方药物评审:瑞扎芬净
Hosp Pharm. 2024 Jun;59(3):245-253. doi: 10.1177/00185787231206523. Epub 2023 Oct 30.
8
Formulary Drug Reviews: Nirsevimab.处方药物评审:尼塞韦单抗
Hosp Pharm. 2024 Apr;59(2):138-145. doi: 10.1177/00185787231212620. Epub 2023 Nov 19.
9
Formulary Drug Review: Sufentanil Sublingual.处方药物评审:舒芬太尼舌下给药制剂
Hosp Pharm. 2019 Aug;54(4):222-228. doi: 10.1177/0018578719851726. Epub 2019 May 29.
10
Formulary Drug Reviews: Terlipressin.处方药物评审:特利加压素
Hosp Pharm. 2023 Dec;58(6):544-548. doi: 10.1177/00185787221150921. Epub 2023 Jan 26.

本文引用的文献

1
Levoketoconazole in the treatment of patients with endogenous Cushing's syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS).左卡尼汀治疗内源性库欣综合征患者的双盲、安慰剂对照、随机撤药研究(LOGICS)。
Pituitary. 2022 Dec;25(6):911-926. doi: 10.1007/s11102-022-01263-7. Epub 2022 Sep 9.
2
Effectiveness of Medical Treatment of Cushing's Disease: A Systematic Review and Meta-Analysis.库欣病治疗效果的系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2021 Sep 17;12:732240. doi: 10.3389/fendo.2021.732240. eCollection 2021.
3
Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study.左卡尼汀治疗库欣综合征合并糖尿病患者的疗效:SONICS 研究 3 期结果。
Front Endocrinol (Lausanne). 2021 Apr 7;12:595894. doi: 10.3389/fendo.2021.595894. eCollection 2021.
4
Approach to the Patient Treated with Steroidogenesis Inhibitors.应用于甾体激素合成抑制剂治疗患者的方法。
J Clin Endocrinol Metab. 2021 Jun 16;106(7):2114-2123. doi: 10.1210/clinem/dgab122.
5
Levoketoconazole, the 2S,4R Enantiomer of Ketoconazole, a New Steroidogenesis Inhibitor for Cushing's Syndrome Treatment.左酮康唑,酮康唑的 2S,4R 对映异构体,一种治疗库欣综合征的新型甾体生成抑制剂。
J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1618-e1630. doi: 10.1210/clinem/dgaa989.
6
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials.库欣病的治疗:当前和近期临床试验概述。
Front Endocrinol (Lausanne). 2020 Dec 8;11:648. doi: 10.3389/fendo.2020.00648. eCollection 2020.
7
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.左卡尼汀改善库欣综合征患者的临床症状和患者报告的结局。
Pituitary. 2021 Feb;24(1):104-115. doi: 10.1007/s11102-020-01103-6. Epub 2020 Nov 20.
8
Advances in the Medical Treatment of Cushing Disease.库欣病的医学治疗进展。
Endocrinol Metab Clin North Am. 2020 Sep;49(3):401-412. doi: 10.1016/j.ecl.2020.05.003. Epub 2020 Jul 2.
9
What is the role of medical therapy in adrenal-dependent Cushing's syndrome?医学治疗在肾上腺依赖型库欣综合征中的作用是什么?
Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101376. doi: 10.1016/j.beem.2020.101376. Epub 2020 Jan 31.
10
Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial.左乙康唑治疗内源性库欣综合征(SONICS)的疗效和安全性:一项 3 期、多中心、开放标签、单臂试验。
Lancet Diabetes Endocrinol. 2019 Nov;7(11):855-865. doi: 10.1016/S2213-8587(19)30313-4. Epub 2019 Sep 18.

左酮康唑

Levoketoconazole.

作者信息

McCartney Nicole K, Baker Danial E

机构信息

Washington State University, Spokane, WA, USA.

出版信息

Hosp Pharm. 2022 Oct;57(5):605-614. doi: 10.1177/00185787221115368. Epub 2022 Aug 2.

DOI:10.1177/00185787221115368
PMID:36081533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9445541/
Abstract

Each month, subscribers to receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of publishes selected reviews in this column. For more information about , contact Wolters Kluwer customer service at 866-397-3433.

摘要

每月,订阅者会收到5至6篇关于新发布或处于3期临床试验后期阶段药物的有充分文献依据的专题论文。这些专题论文面向药学与治疗学委员会。订阅者还会每月收到1页关于对议程以及药房/护理在职培训有用药物的总结专题论文。每月还会提供一份全面的目标药物利用评估/药物使用评估(DUE/MUE)。订阅后,专题论文可供订阅者在线获取。专题论文可进行定制以满足机构需求。通过合作,出版方会在本专栏发表精选评论。如需了解更多关于……的信息,请致电866 - 397 - 3433联系威科集团客户服务部。